Skip to Content

LOGO 200 (Nexavar 200 mg)

Generic Name: sorafenib

Pill with imprint LOGO 200 is Red, Round and has been identified as Nexavar 200 mg. It is supplied by Bayer HealthCare Pharmaceuticals Inc..

Nexavar is used in the treatment of hepatocellular carcinoma; hepatic tumor; thyroid cancer; renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Nexavar 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LOGO 200

Nexavar

Generic Name:
sorafenib
Imprint:
LOGO 200
Strength:
200 mg
Color:
Red
Shape:
Round
Availability:
Prescription only
Drug Class:
Multikinase inhibitors
VEGF/VEGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Bayer HealthCare Pharmaceuticals Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide